Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis	Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis	Active, not recruiting	Phase 2	2026-04-29		NCT06230354

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AstraZeneca	806
Imperial College London	220

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aberdeen Royal Infirmary - NHS Grampian	Aberdeen	United Kingdom	2
Barts Health NHS Trust	London	United Kingdom	13
Cambridge University Hospitals NHS Foundation Trust	Cambridge	United Kingdom	34
Guy's Hospital - Guy's and St Thomas' NHS Foundation Trust	London	United Kingdom	1
Imperial College Healthcare NHS Trust	London	United Kingdom	1
Leeds Teaching Hospitals NHS Trust	Leeds	United Kingdom	25
Liverpool University Hospitals NHS Foundation Trust	Liverpool	United Kingdom	2
Royal Brompton Hospital - Guy's and St Thomas' NHS Foundation Trust	London	United Kingdom	1
Royal Free London NHS Trust	London	United Kingdom	1
Royal Infirmary of Edinburgh - NHS Lothian	Edinburgh	United Kingdom	1
University Hospitals Birmingham NHS Foundation Trust	Birmingham	United Kingdom	12
University Hospitals of Leicester NHS Trust	Leicester	United Kingdom	2